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Abstract: Non-glucose biomarker-DNA oxidative damage biomarker 8-hydroxy-2′deoxyguanosine (8-OHdG) has been successfully detected using a smartphone-enabled glucose
meter. Through a series of immune reactions and enzymatic reactions on a solid lateral flow
platform, 8-OHdG concentration has been converted to a relative amount of glucose, and
therefore can be detected by conventional glucose meter directly. The device was able to detect
8-OHdG concentrations in phosphate buffer saline as low as 1.73 ng mL−1 with a dynamic range
of 1–200 ng mL−1. Considering the inherent advantages of the personal glucose meter, the demonstration of this device, therefore, should provide new opportunities for the monitoring of a
wide range of biomarkers and various target analytes in connection with different molecular
recognition events.
Keywords: 8-OHdG, immunostrip, point-of-care, POCTs, biosensor, DNA oxidative damage

Introduction
In recent years, much effort has been devoted toward developing point-of-care (POC)
devices.1–9 Among them, paper-based POC devices are a special category due to the
advantages of being simple, rapid, on-site, and cost-effective; they have been widely
used in home health care and medical testing,10–12 even environmental monitoring.13–15
The lateral flow immunochromatographic assay, also called lateral flow test, is one of
the simplest and most popular formats of paper-based POC devices and can be used
to detect specific substances, including small molecules,15–18 large proteins,19–21 and
even whole pathogens,10 in a sample by using an immunological reaction. However,
most of these tests are based on qualitative colorimetry, which is not sufficient in
many cases. To overcome this limitation, a number of devices capable of quantitative
analysis have been developed.
As we know, medical devices for POC are very costly to develop and manufacture
and are difficult to commercialize. As a result, few have been commercialized successfully. The blood glucose meter (BGM) is one of the most successfully commercialized
diagnostic devices on the market,22,23 and it is widely used by millions of diabetes
patients to monitor their blood glucose levels every day because of its low cost, compact size, simple operation, and reliable quantitative results.2 The successful launch of
US Food and Drug Administration (FDA)-approved smartphone-enabled BGMs, which
enable the wireless transmission of reminders, test results, and data analysis through
smartphone apps, will attract an even larger number of users.24 Generally, a glucose
meter is capable of detecting glucose as the unique target. Recently, many groups
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have reported methods establishing a direct relationship
between the concentrations of the targets in the samples and
the glucose detected by a BGM, enabling a number of nonglucose targets to be detected quantitatively.2,25,26 However,
most of these methods included much liquid handling, such
as adding and mixing solution, which should be avoided as
much as possible to ensure ease of use. Conversely, a lateral
flow device, as mentioned previously, is supposed to replace
most of the manual solution addition and mixing involved
in the above-mentioned methods.
Here, we describe a novel design that combines the traditional lateral flow strip with a commercialized smartphoneenabled BGM (iBGStar® Blood Glucose Monitoring System)
for portable and quantitative detection of a non-glucose target.
The concept is demonstrated by using an oxidative DNA
damage biomarker, 8-hydroxy-2′-deoxyguanosine (8-OHdG).
The basic design of the device is adapted from our previously
reported colorimetric visual detection platform17 based on a
gold nanoparticles (AuNPs)-based competitive immunoassay.
However, visual detection can provide only qualitative and
semiquantitative results. Thus, to enable quantitative analysis,
we establish a novel method that transforms the detection of
the target to the detection of an enzyme invertase. The enzyme
converts sucrose into glucose for BGM readout.

Materials and methods
Design and detection mechanism
As shown in Figure 1, the test strip is composed of five
components, preloaded with different reagents and pasted
onto a plastic backing plate. The sample pad pretreated with
buffer (50 mM borate buffer, 1% bovine serum albumin

[BSA], and 0.2% Tween 20) is where the strip contacts the
liquid sample. Two conjugation pads, which are composed
of glass fiber material, contain AuNPs-labeled mouse anti-8hydroxyguanosine antibody (Ab; has equal binding affinity to
8-OHdG and 8-hydroxyguanosine) and 8-hydroxyguanosine–
invertase conjugates, respectively. Next to the conjugation
pad II is a flow membrane, which is made of nitrocellulose.
There are two reaction zones on this membrane, which are
called test line and control line. A goat anti-mouse immunoglobulin G (IgG) Ab is used as the test line capture reagent,
whereas a goat anti-invertase Ab is used as the control line
capture reagent. The sample moves along the strip due to
capillary action and finally gets collected by the last part
known as the absorption pad.
To realize non-glucose target detection using a BGM,
the relationship between target recognition and glucose
generation must be established. In our design, as illustrated
in Figure 1, the detection is based on two steps: the first step
is that of competitive-type immunoreactions in the lateral
flow strip (Figure 2A–D) and the second step contains an
enzymatic reaction, which converts sucrose into detectable
glucose for measurement by the smartphone-based BGMs
(Figure 2E–G).
Upon target introduction (Figure 2A), the target moves
along the strip due to capillary force and rehydrates conjugation pads I and II (Figure 2B). 8-OHdG in the sample solution
and invertase-conjugated 8-hydroxyguanosine compete to
bind to the Ab from the conjugation pad I. After that, the
invertase that binds to AuNPs is captured by the test line
(Figure 2C), whereas the free invertase is captured by the
control line (Figure 2D). Ideally, the higher the concentration
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Figure 1 Design of a test strip for quantitative detection of 8-OHdG.
Abbreviations: Ab, antibody; AuNPs, gold nanoparticles; 8-OHdG, 8-hydroxy-2′-deoxyguanosine; IgG, immunoglobulin G.
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Figure 2 Mechanism for non-glucose target (8-OHdG) detection by a smartphone-based BGM.
Notes: (A) Sample loading, (B) immunoreactions and migration, (C) capture of antibody from the first conjugation pad on the test zone, (D) capturing the rest enzyme
on the control zone, (E) cut the test and control zones and put them on a hydrophobic plate, (F) add the sucrose solution (20 µL) on top of each zone, (G) after a specific
period of time, measure the concentration of glucose produced on each zone by iBGStar Blood Glucose Monitoring System.
Abbreviations: Ab, antibody; AuNPs, gold nanoparticles; BGM, blood glucose meter; 8-OHdG, 8-hydroxy-2′-deoxyguanosine; IgG, immunoglobulin.

of 8-OHdG in the sample solution is the less invertase
captured on the test line and the more invertase captured
on the control line. Following the first step (~10 min), the
test (3 mm) and control (3 mm) lines are cut by scissors and
put on a hydrophobic plate (Figure 2E). Twenty microliters of 0.5 M sucrose solution is added on top of each line
(Figure 2F). After a certain period of time, the invertase fixed
International Journal of Nanomedicine 2017:12

on each line catalyzes the hydrolysis of sucrose to produce
a specific amount of glucose for quantitative readout by the
smartphone-based BGMs (Figure 2G).

Reagents
BSA, invertase from baker’s yeast (Saccharomyces cerevisiae), sucrose, gold chloride trihydrate, sodium borohydride
submit your manuscript | www.dovepress.com
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(NaBH 4), sodium periodate (NaIO 4), ethylene glycol,
potassium carbonate (K2CO3), boric acid, sodium chloride,
and sodium phosphate were received from Sigma-Aldrich
(St Louis, MO, USA). Trehalose, phosphate buffer saline
(PBS, 1X, pH =7.4), and trisodium citrate dihydrate were
purchased from VWR (West Chester, PA, USA). Tween 20
was obtained from Fisher Scientific (Fairlawn, NJ, USA).
Plastic backing, nitrocellulose membrane, absorbing pad,
and cellulose paper were acquired from Millipore (Billerica,
MA, USA). 8-OHdG and 8-hydroxyguanosine were purchased from Cayman Chemical (Ann Arbor, MI, USA).
Mouse monoclonal antibodies to 8-hydroxyguanosine,
polyclonal goat anti-mouse IgG, and polyclonal goat antiinvertase IgG were purchased from Abcam (Cambridge, MA,
USA). The iBGStar Blood Glucose Monitoring System and
Blood Glucose Test Strips for iBGStar were obtained from
Walgreens (Springfield, IL, USA).

Synthesis of AuNPs-labeled anti-8hydroxyguanosine Ab conjugates for
conjugation pad I
The AuNPs-labeled anti-8-hydroxyguanosine Ab conjugates
were synthesized according to our previously published
method.17 The Supplementary materials also include a detail
instruction for the synthesis. For the conjugation, the AuNPs
solution (~20 nm) was concentrated fivefold and the pH was
adjusted to 8.5–9.0 with 0.1 M K2CO3 in advance for labeling.
The Ab with optimal concentration (45 µL, 0.54 mg mL−1)
was added to the AuNPs solution (560 µL, 5X) and stirred
gently at room temperature for 1 h. The conjugate was stabilized by adding 65 μL 10% BSA in 20 mM sodium borate
for a final concentration of 1% and incubated for another
20 min. Then the mixture was centrifuged for 15 min at
7,000 rcf. The supernatant was discarded, and the pellet was
resuspended in 600 μL 1% BSA/PBS. Following the same
centrifugation step, the supernatant was removed and the soft
sediment of conjugates was finally resuspended in 600 μL
conjugation buffer, containing 20 mM sodium phosphate,
0.25% Tween 20, 10% trehalose, and 5% BSA. The conjugate
was stored at 4°C until required for use. Characterization of
AuNP and its conjugation is documented in the Supplementary materials.

Preparation of 8-hydroxyguanosine–
invertase conjugates for conjugation pad II
8-hydroxyguanosine (0.8 mg) was dissolved in 800 μL
1X PBS. The solution (1 mg mL−1) was mixed with NaIO4
(200 μL, 50 mM) and the mixture was incubated for 1 h in
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the dark. The reaction was stopped by adding ethylene glycol
(2.5 µL) for 5 min. Then the mixture (500 μL) was mixed
with invertase (2.5 mL, 29 g L−1, pH =9.5, adjusted by K2CO3
[50 g L−1]) by adding it dropwise under constant stirring and
incubated for another 1 h. After that, NaBH4 (2 mL, 12 g L−1)
was added and the mixture was incubated in the dark at 4°C
overnight (12–16 h). Finally, the conjugates were dialyzed
against 1X PBS and stored at −20°C.

Assembly of the lateral flow immuno
strip
The goat anti-mouse IgG Ab (1 mg mL−1) was used as the test
line capture reagent, whereas the goat anti-invertase IgG Ab
(3.3 mg mL−1) was used as the control line capture reagent.
These capture reagents were dispensed by the Linomat 5
dispenser onto a nitrocellulose membrane as the test and
control lines. The sample pad was pretreated with buffer
(50 mM borate buffer, 1% BSA, and 0.2% Tween 20), then
AuNPs-labeled anti-8-hydroxyguanosine Ab (20 μL) and
8-hydroxyguanosine–invertase conjugates (20 μL) were
dispensed by pipette onto glass fiber pads, which were called
the conjugate pad I and II, respectively. After drying these
membranes, the sample pad, conjugate pads, nitrocellulose
membrane, and absorbent pad were pasted onto a plastic
backing plate, which was already cut into 5-mm wide strips
using a strip cutter. Then the strips were stored in a selfsealing plastic bag until use.

Results and discussion
Check the properties of
8-hydroxyguanosine–invertase conjugates
One of the most important components in the design is
8-hydroxyguanosine–invertase conjugates. This is synthesized according to a well-established method.27 The method
requires several steps of chemical reactions that might affect
the structure and function of the enzyme to a certain extent.
Thus, two aspects of the functions of the conjugates were
examined before being used for conjugation pad II: enzymatic activity (invertase part) for glucose production and
antigenic activity (8-hydroxyguanosine part) for competitive
immunoreactions.
The enzymatic activity of the conjugates (invertase part)
was tested by mixing 10 μL of conjugates solution with 50 μL
of 0.5 M sucrose solution. The BGM readout of the modified
invertase was 134±5 mg dL−1 (n=3) after 2 min, while that
of the original invertase was 148±7 mg dL−1 (n=3), indicating that the modified invertase retains a high enzymatic
activity after the chemical modifications. The antigenic
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Figure 3 Mechanism of competitive lateral flow immunoassay for 8-OHdG testing.
Abbreviations: Ab, antibody; AuNPs, gold nanoparticles; BSA, bovine serum albumin; 8-OHdG, 8-hydroxy-2′-deoxyguanosine.

activity of the conjugates was tested through our previously
published method.17 As illustrated in Figure 3, competitive
type strips are designed for testing small molecules with
single antigenic determinants (ie, 8-OHdG), which cannot
bind to two antibodies simultaneously. Both 8-OHdG in the
sample solution and 8-hydroxyguanosine on the test line
compete to bind to the Ab from the conjugation pad. As a
result, the intensity of the test line is inversely proportional
to the concentration in the sample. Our previous publication has verified that 8-hydroxyguanosine–BSA conjugates
maintain considerable Ab capturing capacity. In this study,
we compare 8-hydroxyguanosine–invertase conjugates with
8-hydroxyguanosine–BSA conjugates in terms of this capacity (see test line in Figure 4). These two conjugates show no
difference at both low (0 ng mL−1) and high (1,000 ng mL−1)
8-OHdG sample loading, demonstrating the feasibility of the
function of 8-hydroxyguanosine in the 8-hydroxyguanosine–
invertase conjugates for the following application.

Optimization of the amount of
8-hydroxyguanosine–invertase conjugates
used on conjugation pad II and of the
time for enzymatic reaction
The amount of 8-hydroxyguanosine–invertase conjugates
used on conjugation pad II played an important role in the
performance of this detection system. We tested five concentrations of conjugates (original 14.5 mg mL−1, diluted
5-fold, diluted 10-fold, diluted 20-fold, and diluted 30-fold)

International Journal of Nanomedicine 2017:12

on conjugation pad II. Two concentration levels, PBS buffer
(0 ng mL−1) and high concentration (50 ng mL−1), were
prepared and applied to these five types of strips. After
10 min, the test (3 mm) and control (3 mm) lines were cut by
scissors and put on a hydrophobic plate. Twenty microliters of
0.5 M sucrose solution was added on top of each line. After a
certain period of time, the invertase fixed on each line catalyzes the hydrolysis of sucrose to produce a specific amount
of glucose for quantitative BGM readout. At the same time,
the catalytic reaction time was also optimized. The readouts

3%6EXIIHU
QJP/±

2+G*VROXWLRQ
QJP/±

7HVWOLQH
K\GUR[\JXDQRVLQH±
%6$FRQMXJDWHV
&RQWUROOLQHJRDW
DQWLPRXVH,J*
7HVWOLQH
K\GUR[\JXDQRVLQH±
LQYHUWDVHFRQMXJDWHV
&RQWUROOLQHJRDW
DQWLPRXVH,J*
Figure 4 The photographs of test strips based on two samples (0 and 1,000 ng mL−1).
Notes: Top row: 8-hydroxyguanosine–BSA conjugates were used as the capture
reagents on the test line; bottom row: 8-hydroxyguanosine–invertase conjugates
were used as the capture reagents on the test line. Left three columns: samples with
a concentration of 0 ng mL−1; right three columns: samples with a concentration of
1,000 ng mL−1.
Abbreviations: BSA, bovine serum albumin; 8-OHdG, 8-hydroxy-2′-deoxy
guanosine; IgG, immunoglobulin G; PBS, phosphate buffer saline.
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RRR =

 Readout of test line 
Ratio 
 Readout of control line  (50 ng mLL−1)
 Readout of test line 
Ratio 
 Readout of control line  (0 ng mL−1)

Under the optimized conditions, a series of 8-OHdG solutions with concentrations of 0, 1, 10, 50, 100, 200, and
1,000 ng mL−1 in 1X PBS buffer were prepared and applied
to the strips. After 10 min, the test (3 mm) and control (3 mm)
lines were cut by scissors and put on a hydrophobic plate.
Twenty microliters of 0.5 M sucrose solution was put on top
of each line, and a smartphone-enabled BGM was used for
readout after 40 min. As shown in Figure 6, the normalized
readout ratio (NRR) defined as



decreased when the concentration increased, which is
consistent with the theory of the competitive format of
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Figure 5 RRR for five concentrations of 8-hydroxyguanosine (8-OHdG) invertase
conjugates used on the conjugation pad II.
Abbreviation: RRR, relative readout ratio.
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>2+G*@ QJP/±
Figure 6 Detection of 8-OHdG in buffer based on the smartphone-based blood
glucose meter.
Notes: The concentration of 8-OHdG was varied from 0 to 1,000 ng mL−1. Insert:
linear relationship between NRR and the logarithm of 8-OHdG concentration, three
measurements for each point.
Abbreviations: 8-OHdG, 8-hydroxy-2′-deoxyguanosine; NRR, normalized readout
ratio.

detection. From this figure, we can see that NRR has no
obvious change when the concentration is .200 ng mL−1.
However, elevated concentrations of 8-OHdG from 0 to
200 ng mL−1 lead to obviously decreased NRR. A dynamic
range of 1–200 ng mL−1 can be obtained with R2=0.995, and
as low as 1.73 ng mL−1 of 8-OHdG can be detected. Considering the cut-off value of 8-OHdG for healthy adults is
20–40 ng mL−1, our approach is, therefore, suitable for early
diagnosis of 8-OHdG.

Conclusion

 Readout of test line 
Ratio 
 Readout of control line  (concenntration [ng mL−1 ])
 Readout of test line 
Ratio 
 Readout of control line  (blank [ng mL−1 ])

\ ±[
5 







Quantitative detection of 8-OHdG
by a BGM


2ULJLQDO





was used to determine the efficiency of the strips to distinguish one concentration from another (Figure 5). As a result,
20-fold diluted conjugates and 40-min reaction time were
chosen for the following experiment.

NRR =



155

of the BGM at 20 and 40 min time points were collected
respectively, from which we found that 20 min is not enough
for some low concentrations (diluted 10-fold, 20-fold, and
30-fold). However, the relative readout ratio defined as

In conclusion, we have developed a simple approach for
quantitative detection of 8-OHdG by using a low-cost strip
and an easily accessible smartphone-based BGM. The cost
for strips as demonstrated in this work is ~10 USD/pc, of
which the majority comes from the purchase of 8-OHdG
antibodies from commercial vendors. The device was able to
detect 8-OHdG concentrations in PBS as low as 1.73 ng mL−1
with a dynamic range of 1–200 ng mL−1 in ,1 h. The strip
was easy to fabricate and convenient to operate, and the
assay did not require any specialized skills or sophisticated
instrument. In addition, because of the advantages of the
BGM, the demonstration of this approach will provide new
opportunities for the detection of other targets. Our current
areas of focus are expanding the scope of the strip-BGM
design to include other targets and even real biomedical
samples testing, further simplifying the design to eliminate
the need for target–invertase conjugates to be loaded on conjugation pad II enabling various types of target measurements
and optimizing the experimental conditions to acquire a

International Journal of Nanomedicine 2017:12
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comparable sensitivity compared with other commercialized
test kits. The results of these experiments will be reported
in due course.
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Preparation of AuNPs

characterized by the Zetasizer after the solution reached
room temperature.

A well-established citrate reduction method was employed
to generate AuNPs of various diameters. Different sizes
of AuNPs produce different reflected color. AuNPs with a
diameter of ~20 nm intrinsically give a better visibility on
paper-based strip when accumulated on the test line, and
therefore we used AuNPs with an average size ~20 nm in
this work.
Briefly, the hydrogen tetrachloroaurate solution (50 mL,
0.01% ) was added to a Erlenmeyer flask (250 mL), stirred,
and brought to the boil on a hotplate. Trisodium citrate
solution (1 mL, 1%) was added rapidly to the boiling solution under constant stirring. Gradually, the color changed
from pale yellow to wine red. After the color change
ceased, the solution was boiled for another 10 min and
stirred without heating for another 10 min to complete the
reduction of the gold chloride. The size of the particles was
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Characterization of AuNPs pre- and postconjugation
The wine red-colored solution contains AuNPs with a size
of ~20 nm (Zetasizer, Figure S1A) and its corresponding
maximum absorbance is exhibited at 520 nm as shown in
Figure S1B (ultraviolet–visible spectrophotometer). It is well
known that the strong absorbance at 520 nm is attributed to
the surface plasmon resonance of AuNPs and the maximum
absorption peak will be shifted or disappeared if the nanoparticles aggregate or get further modifications.
As a quality control step post-conjugation, the absorbance
spectrum was again measured and compared with that of
AuNPs that do not get antibody modifications. A ~3 nm red
shift was observed as an indication for successful conjugations (Figure S2).
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Figure S1 Characterization of synthesized AuNPs and antibody-AuNP conjugation. (A) Intensity distribution versus size of AuNPs solution (average size, ~20 nm) measure
by Zetasizer; (B) ultraviolet–visible spectrum of ~20 nm AuNPs.
Abbreviations: AU, arbitrary unit; AuNPs, gold nanoparticles; Rel, relative.
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Figure S2 Antibody conjugation of gold nanoparticles produces a red shift in the ultraviolet–visible spectrometer.
Abbreviations: AU, arbitrary unit; N, normalized.

986

submit your manuscript | www.dovepress.com

Dovepress

International Journal of Nanomedicine 2017:12

Dovepress

Glucose biosensor for DNA oxidative damage assessment

Dovepress

International Journal of Nanomedicine

Publish your work in this journal
The International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology
in diagnostics, therapeutics, and drug delivery systems throughout
the biomedical field. This journal is indexed on PubMed Central,
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine,

Journal Citation Reports/Science Edition, EMBase, Scopus and the
Elsevier Bibliographic databases. The manuscript management system
is completely online and includes a very quick and fair peer-review
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.

Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal

International Journal of Nanomedicine 2017:12

submit your manuscript | www.dovepress.com

Dovepress

987

